FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

1514151000168100: Australian Black Triangle Scheme reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Dec 2020. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4501271000168110 Australian Black Triangle Scheme reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4501281000168113 Australian Black Triangle Scheme reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501291000168111 Black Triangle Scheme reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501301000168112 BTS (Black Triangle Scheme) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501421000168113 <p>Supports the identification of AMT TPUU and CTPP concepts that are associated with medicines where reporting adverse events are encouraged under the Black Triangle Scheme. </p><p>This reference set can be used by prescribing and dispensing software vendors to identify medications where reporting of adverse events is encouraged under the Black Triangle Scheme.</p><p><span><b>Target client</b>: This reference set was developed by the National Clinical Terminology Service, based on information from the Therapeutic Goods Administration (TGA), to support the reporting of adverse events, and can be used by developers to assist with the identification of medicines associated with the Black Triangle Scheme.</span><br></p> en Definition Active Case sensitive Australian Medicines Terminology module


1411 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Black Triangle Scheme reference set Is a Reference sets for Medications true Inferred relationship Some
Black Triangle Scheme reference set Is a Simple type reference set true Inferred relationship Some
Black Triangle Scheme reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 494774926
Black Triangle Scheme reference set Developed by Australian Digital Health Agency true Inferred relationship Some 254185599

Members
Bilura 20 mg tablet
Bilura 20 mg tablet, 28, blister pack
Bilura 20 mg tablet, 30, blister pack
Bilura 40 mg tablet
Bilura 40 mg tablet, 28, blister pack
Bilura 40 mg tablet, 30, blister pack
Bilura 80 mg tablet
Bilura 80 mg tablet, 28, blister pack
Bilura 80 mg tablet, 30, blister pack
Braftovi 50 mg capsule
Braftovi 50 mg capsule, 28, blister pack
Braftovi 75 mg capsule
Braftovi 75 mg capsule, 42, blister pack
Brineura (2 x 5 mL vials, 1 x 5 mL inert solution vial), 1 pack
Brineura (cerliponase alfa 150 mg/5 mL) injection, 5 mL vial
Brineura (inert substance) solution, 5 mL vial
Briviact (brivaracetam 10 mg / 1 mL) oral liquid (trade product unit of use)
Briviact 10 mg/mL oral liquid, 300 mL, bottle
Briviact 10 mg tablet
Briviact 10 mg tablet, 100, blister pack
Briviact 10 mg tablet, 14, blister pack
Briviact 10 mg tablet, 168, blister pack
Briviact 10 mg tablet, 56, blister pack
Briviact 100 mg tablet
Briviact 100 mg tablet, 100, blister pack
Briviact 100 mg tablet, 14, blister pack
Briviact 100 mg tablet, 168, blister pack
Briviact 100 mg tablet, 56, blister pack
Briviact 25 mg tablet
Briviact 25 mg tablet, 100, blister pack
Briviact 25 mg tablet, 14, blister pack
Briviact 25 mg tablet, 168, blister pack
Briviact 25 mg tablet, 56, blister pack
Briviact 50 mg/5 mL injection, 10 x 5 mL vials
Briviact 50 mg/5 mL injection, 5 mL vial
Briviact 50 mg tablet
Briviact 50 mg tablet, 100, blister pack
Briviact 50 mg tablet, 14, blister pack
Briviact 50 mg tablet, 168, blister pack
Briviact 50 mg tablet, 56, blister pack
Briviact 75 mg tablet
Briviact 75 mg tablet, 100, blister pack
Briviact 75 mg tablet, 14, blister pack
Briviact 75 mg tablet, 168, blister pack
Briviact 75 mg tablet, 56, blister pack
Brukinsa 80 mg capsule
Brukinsa 80 mg capsule, 120, bottle
Cabenuva (1 x Cabotegravir 400 mg/2 mL vial, 1 x Rilpivirine 600 mg/2 mL vial), 1 pack
Cabenuva (1 x Cabotegravir 600 mg/3 mL vial, 1 x Rilpivirine 900 mg/3 mL vial), 1 pack
Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial
Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial
Cabenuva Cabotegravir 600 mg/3 mL modified release injection, 3 mL vial
Cabenuva Cabotegravir 600 mg/3 mL modified release injection, 3 mL vial
Cabenuva Rilpivirine 600 mg/2 mL modified release injection, 2 mL vial
Cabenuva Rilpivirine 600 mg/2 mL modified release injection, 2 mL vial
Cabenuva Rilpivirine 900 mg/3 mL modified release injection, 3 mL vial
Cabenuva Rilpivirine 900 mg/3 mL modified release injection, 3 mL vial
Cablivi (1 x 10 mg vial, 1 x 1 mL inert diluent syringe), 1 pack
Cablivi (7 x 10 mg vials, 7 x 1 mL inert diluent syringes), 1 pack
Cablivi (caplacizumab 10 mg) powder for injection, 10 mg vial
Cablivi (inert substance) diluent, 1 mL syringe
Cabometyx 60 mg tablet
Cabometyx 60 mg tablet, 30, bottle
Calquence 100 mg capsule
Calquence 100 mg capsule, 56, blister pack
Calquence 100 mg tablet
Calquence 100 mg tablet, 56, blister pack
Casirivimab (Roche) 120 mg/mL injection, 2.5 mL vial
Casirivimab (Roche) 120 mg/mL injection, 2.5 mL vial
Casirivimab (Roche) Multidose 120 mg/mL injection, 11.1 mL vial
Casirivimab (Roche) Multidose 120 mg/mL injection, 11.1 mL vial
Casirivimab and Imdevimab (Roche) Multidose (1 x Casirivimab 11.1 mL vial, 1 x Imdevimab 11.1 mL vial), 1 pack
Cequa 0.09% eye drops, 0.25 mL unit dose
Cequa 0.09% eye drops, 10 x 0.25 mL unit doses, ampoule
Cequa 0.09% eye drops, 60 x 0.25 mL unit doses, ampoule
Comirnaty Grey Cap 12 Years and Above Ready to Use Multidose 30 microgram/0.3 mL injection, 10 x 2.25 mL vials
Comirnaty Grey Cap 12 Years and Above Ready to Use Multidose 30 microgram/0.3 mL injection, 195 x 2.25 mL vials
Comirnaty Grey Cap 12 Years and Above Ready to Use Multidose 30 microgram/0.3 mL injection, 2.25 mL vial
Comirnaty Maroon Cap 6 Months to less than 5 Years Dilute to Use Multidose injection, 0.4 mL vial
Comirnaty Maroon Cap 6 Months to less than 5 Years Dilute to Use Multidose injection, 10 x 0.4 mL vials
Comirnaty Maroon Cap 6 Months to less than 5 Years Dilute to Use Multidose injection, 195 x 0.4 mL vials
Comirnaty Orange Cap 5 to less than 12 Years Dilute to Use Multidose injection, 1.3 mL vial
Comirnaty Orange Cap 5 to less than 12 Years Dilute to Use Multidose injection, 10 x 1.3 mL vials
Comirnaty Orange Cap 5 to less than 12 Years Dilute to Use Multidose injection, 195 x 1.3 mL vials
Comirnaty Original/Omicron BA.1 Multidose injection, 10 x 2.25 mL vials
Comirnaty Original/Omicron BA.1 Multidose injection, 195 x 2.25 mL vials
Comirnaty Original/Omicron BA.1 Multidose injection, 2.25 mL vial
Comirnaty Original/Omicron BA.4-5 Multidose injection, 10 x 2.25 mL vials
Comirnaty Original/Omicron BA.4-5 Multidose injection, 195 x 2.25 mL vials
Comirnaty Original/Omicron BA.4-5 Multidose injection, 2.25 mL vial
Comirnaty Purple Cap Multidose injection, 0.45 mL vial
Comirnaty Purple Cap Multidose injection, 195 x 0.45 mL vials
Constella 145 microgram capsule
Constella 145 microgram capsule, 30, bottle
Constella 145 microgram capsule, 4, bottle
Constella 290 microgram capsule
Constella 290 microgram capsule, 30, bottle
Constella 290 microgram capsule, 4, bottle
Constella 72 microgram capsule
Constella 72 microgram capsule, 30, bottle
Constella 72 microgram capsule, 4, bottle

Start Page 2 of 15 Next End


Reference Sets

Reference set descriptor

Back to Start